on EoE and IBD
Meeting Details


6:30pm – 9:00pm


Docklands VIC 3008
Presented by:



AGENDA
RSVP: Please RSVP by Thursday 17 July 2025
Parking: Parking available on-site: the WTC Wharf carpark is located at 18-38 Siddeley Street, Docklands 3008, with parking costs covered by Dr Falk on the night (please note, only WTC Wharf carpark costs will be covered). Please bring the ticket to the registration desk at the close of the meeting where your parking will be validated.
Contact: Clinton Fernandes on 0435 869 491 or clinton.fernandes@drfalkpharma.com.au
SPEAKERS

Prof. Dr. Luc Biedermann has been a board-certified specialist for Gastroenterology & Hepatology and Internal Medicine since 2012. His special focus as a clinician in the Department of Gastroenterology & Hepatology of the University Hospital Zurich (USZ), Switzerland, is Inflammatory Bowel Disease (IBD), Eosinophilic Oesophagitis (EoE) and other immune mediated gastrointestinal diseases. Since 2017 he has been head of IBD and EoE within the USZ department of Gastroenterology & Hepatology. His main clinical and research interests include epidemiology, natural history and course of disease, environmental factors, intestinal microbiota as well as drug development and clinical trials in IBD and EoE. Regarding EoE, it has been his pleasure for many years to host Prof. Dr. Alex Straumann, who first described EoE in 1994 (simultaneously and independently with Prof. Steven Attwood), for an intensive research collaboration and joint specialised unique outpatient EoE clinic at the USZ.

A/Prof Britt Christensen is the Head of the Inflammatory Bowel Disease Unit at The Royal Melbourne Hospital (RMH) and a clinical Associate Professor at The University of Melbourne. She studied Medicine at the University of Melbourne, and has completed a Masters of Public Health at Monash University, for which she was awarded a Medal of Academic Excellence. After completing her gastroenterology training, she was awarded the Joseph B. Kirsner fellowship and spent over 2 years undertaking advanced training in IBD at the prestigious University of Chicago Medicine.
Britt's research interests include treat-to-target end-points, biomarkers of disease activity, intestinal ultrasound for disease monitoring and pregnancy in IBD. She is a co-founder of the Victorian Immune Disease Tissue BioBank, a joint collaboration between The Royal Melbourne Hospital and WEHI. She set-up the intestinal ultrasound unit and the pregnancy-IBD service at RMHI, is a board member of the international bowel ultrasound group and vice-chair of the international bowel ultrasound group scientific committee.
Britt is the Chair-elect of the Australian IBD Faculty, incoming board member of GESA and is on the GESA research committee. In addition, she is the author of several book chapters on IBD, is a reviewer for many of the top journals in the field of gastroenterology and supervises several honours and PhD students.

A/Prof Greg Moore is Head of IBD at Monash Medical Centre in Melbourne and an Associate Professor at Monash University. He is a former Chair of the Australian Inflammatory Bowel Diseases Association and a Board member of Crohn's and Colitis Australia and Chair of the Medical and Scientific Committee of CCA.
He graduated from Monash University and completed Gastroenterology training at Monash Medical Centre and St. Vincent's Hospital Melbourne. He then undertook a basic science PhD at the University of Melbourne, and returned to found the Inflammatory Bowel Diseases Unit at Monash Medical Centre in 2007 where he oversees a multi-disciplinary IBD clinic providing tertiary referral services to the South East of Melbourne and country Victoria. Greg combines ongoing translational and clinical research and is an active undergraduate and post-graduate teacher.
REGISTRATION FORM
* indicates required fields
Please direct any questions to Clinton Fernandes on 0435 869 491 or clinton.fernandes@drfalkpharma.com.au
After registering, you will receive a confirmation email which can be saved directly into your calendar.
This meeting is for Healthcare Professionals only. In registering for this meeting, I understand that Personal information collected from me by Dr Falk Pharma Australia when I respond to this invitation will be used for communication about this meeting and other Dr Falk Pharma Australia initiatives. Your personal information will be treated in accordance with applicable laws and in accordance with Dr Falk Pharma Australia policies. For more information, please contact our Privacy Officer by email at privacy@drfalkpharma.com.au or phone 1800 373 255. Copyright © 2025 Dr Falk
Dr. Falk Pharma Australia Pty Ltd. ABN 40 631 091 131. 9 Help Street, Chatswood NSW 2067. Website: www.drfalkpharma.com.au Tel: 1800 DRFALK (1800 373 255). Email: admin@drfalkpharma.com.au
Date of preparation: June 2025. DRF376. COR-2025-1499.